MoneyWorks4Me

Concord Drugs - Quaterly Results

11 Jan 2025 Evaluate
The sales declined to Rs. 107.74 millions for the December 2024 quarter as compared to Rs. 126.24 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2024 of Rs. 2.22 millions grew from Rs.-2.39 millionsOperating profit for the quarter ended December 2024 rose to 13.14 millions as compared to 5.62 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 107.74 126.24 -14.65 289.78 288.02 0.61 432.70 513.23 -15.69
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 13.14 5.62 133.81 28.50 34.98 -18.52 36.87 43.52 -15.28
Interest 4.26 4.32 -1.39 11.84 12.12 -2.31 15.90 16.24 -2.09
PBDT 8.88 1.30 583.08 16.66 22.86 -27.12 20.97 27.28 -23.13
Depreciation 3.67 3.85 -4.68 10.43 11.48 -9.15 15.38 16.03 -4.05
PBT 5.21 -2.55 -304.31 6.23 11.38 -45.25 5.59 11.25 -50.31
TAX 2.99 -0.16 -1968.75 3.34 3.63 -7.99 1.39 2.33 -40.34
Deferred Tax 1.55 -0.11 -1509.09 1.36 -0.54 -351.85 -0.63 -1.14 -44.74
PAT 2.22 -2.39 -192.89 2.89 7.75 -62.71 4.20 8.92 -52.91
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 93.16 7.34
PBIDTM(%) 12.20 4.45 173.96 9.84 12.14 -19.02 8.52 8.48 0.49
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..